International approval for Australian pharmaceutical testing

University of Queensland-based contract research organisation TetraQ is now recognised to provide internationally accredited testing services to the Australian biopharmaceutical industry.

TetraQ has attained official Good Laboratory Practice recognition from the National Association of Testing Authorities for one of its key laboratories. The laboratory is ADME (absorption, distribution, metabolism and elimination).

With Good Laboratory Practice status, the laboratory's bioanalytical work will be accepted internationally for regulatory review.

The company's compliance with the strict international Good Laboratory Practice code will allow new pharmaceuticals being developed to be analysed in Australia rather than being sent off-shore, according to TetraQ executive director, Professor Maree Smith.

Neuprotect Pty Ltd CEO Dr Nicole Fowler said she was delighted with TetraQ ADME's Good Laboratory Practice compliance and the implications for her Melbourne-based biotechnology company.

"We know through interaction and first-hand observation that the integrity of TetraQ's data is sound, and knowing that the ADME laboratory has Good Laboratory Practice recognition will allow our critical data to have more credibility in the eyes of international regulatory agencies," Fowler said.